Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Hypersensitivity | 2 | 2022 | 845 | 0.920 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2019 | 354 | 0.640 |
Why?
|
| Ribavirin | 1 | 2012 | 399 | 0.410 |
Why?
|
| Cholecalciferol | 1 | 2014 | 433 | 0.400 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2012 | 257 | 0.380 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 2256 | 0.360 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1734 | 0.350 |
Why?
|
| Renal Dialysis | 1 | 2014 | 1601 | 0.290 |
Why?
|
| Electronic Health Records | 1 | 2022 | 3836 | 0.290 |
Why?
|
| Lung Transplantation | 1 | 2012 | 1105 | 0.260 |
Why?
|
| Dietary Supplements | 1 | 2014 | 2955 | 0.230 |
Why?
|
| Antiviral Agents | 1 | 2012 | 2625 | 0.200 |
Why?
|
| Cyclooxygenase 1 | 1 | 2019 | 114 | 0.190 |
Why?
|
| Ribosomal Proteins | 2 | 2011 | 379 | 0.170 |
Why?
|
| Cross Reactions | 1 | 2019 | 912 | 0.160 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2019 | 395 | 0.160 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 646 | 0.160 |
Why?
|
| Documentation | 1 | 2022 | 806 | 0.150 |
Why?
|
| Administration, Oral | 2 | 2014 | 3975 | 0.150 |
Why?
|
| Antigen Presentation | 2 | 2011 | 1364 | 0.130 |
Why?
|
| Peptide Biosynthesis | 1 | 2011 | 70 | 0.110 |
Why?
|
| Immunologic Surveillance | 1 | 2011 | 110 | 0.100 |
Why?
|
| Neuraminidase | 1 | 2009 | 209 | 0.100 |
Why?
|
| Safety | 1 | 2014 | 1247 | 0.100 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 1119 | 0.100 |
Why?
|
| Antigens, Viral | 2 | 2011 | 1146 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2010 | 343 | 0.090 |
Why?
|
| Seawater | 1 | 2007 | 106 | 0.090 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2011 | 4115 | 0.090 |
Why?
|
| Chemokines | 1 | 2011 | 958 | 0.080 |
Why?
|
| Monocytes | 2 | 2014 | 2643 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 622 | 0.080 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2009 | 462 | 0.070 |
Why?
|
| Biodiversity | 1 | 2007 | 331 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2010 | 1354 | 0.070 |
Why?
|
| Fungi | 1 | 2007 | 328 | 0.070 |
Why?
|
| Ecosystem | 1 | 2007 | 335 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2010 | 872 | 0.070 |
Why?
|
| Dendritic Cells | 2 | 2011 | 2779 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2214 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2014 | 7791 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2022 | 67320 | 0.050 |
Why?
|
| H-2 Antigens | 2 | 2011 | 413 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2011 | 5989 | 0.050 |
Why?
|
| Lymph Nodes | 1 | 2011 | 3425 | 0.050 |
Why?
|
| Ovalbumin | 2 | 2011 | 722 | 0.050 |
Why?
|
| Survival Rate | 1 | 2012 | 13606 | 0.040 |
Why?
|
| Phenotype | 1 | 2014 | 16091 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 4355 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2014 | 10329 | 0.040 |
Why?
|
| Disease Progression | 1 | 2012 | 13204 | 0.040 |
Why?
|
| Inflammation | 1 | 2014 | 9617 | 0.030 |
Why?
|
| Humans | 4 | 2022 | 686663 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 16227 | 0.030 |
Why?
|
| Time Factors | 1 | 2014 | 42271 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11833 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 2011 | 794 | 0.030 |
Why?
|
| Vaccinia virus | 1 | 2011 | 326 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2009 | 212 | 0.020 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 449 | 0.020 |
Why?
|
| Protein Stability | 1 | 2011 | 563 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 651 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2011 | 882 | 0.020 |
Why?
|
| Middle Aged | 2 | 2014 | 216468 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2010 | 319 | 0.020 |
Why?
|
| Oceans and Seas | 1 | 2007 | 44 | 0.020 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2007 | 60 | 0.020 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2009 | 225 | 0.020 |
Why?
|
| Morpholines | 1 | 2011 | 594 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2011 | 5167 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 24351 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 883 | 0.020 |
Why?
|
| Female | 3 | 2014 | 375459 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 60991 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 56052 | 0.020 |
Why?
|
| Male | 2 | 2014 | 352465 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 2103 | 0.020 |
Why?
|
| Gene Library | 1 | 2007 | 1110 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2238 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 4269 | 0.020 |
Why?
|
| Adolescent | 1 | 2012 | 84957 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2010 | 2950 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 2101 | 0.020 |
Why?
|
| Mice | 4 | 2011 | 80803 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2009 | 3969 | 0.020 |
Why?
|
| Epitopes | 1 | 2009 | 2716 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 3983 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 23439 | 0.010 |
Why?
|
| Phylogeny | 1 | 2007 | 2863 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 162271 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 4345 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 10094 | 0.010 |
Why?
|
| Animals | 4 | 2011 | 170849 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 211400 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6464 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 14656 | 0.010 |
Why?
|
| Macrophages | 1 | 2011 | 5748 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 19328 | 0.010 |
Why?
|
| Computational Biology | 1 | 2007 | 3612 | 0.010 |
Why?
|
| Cell Line | 1 | 2009 | 17137 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2010 | 15597 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17251 | 0.010 |
Why?
|
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_